Skip to search formSkip to main contentSkip to account menu

Busulfex

National Institutes of Health

Related topics

Related topics

3 relations
10 ML Busulfan 6 MG/ML Injection [Busulfex]Busulfan Injection [Busulfex]

Broader (1)

Busulfan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
[Clinical Efficacy of Haploidentical Allo-HSCT of Reduced Intensity Preconditioning Combined with Induced Immune Tolerance after Transplantation for Severe Aplastic Anemia].
OBJECTIVE To investigate the efficacy and safety of haploidentical allo-HSCT in combination of reduced intensity preconditioning… 
2014
2014
[Clinical analysis of reduced conditioning intensity allo-HSCT treatment for relapsed ETO-positive AML].
This study was aimed to explore the effect and feasibility of reduced conditioning intensity allogeneic hematopoietic stem cell… 
2011
2011
Mini Test Dose of Intravenous Busulfan (Busulfex®) in Allogeneic Non-Myeloablative Stem Cell Transplantation, Followed by Liquid Chromatography Tandem-Mass Spectrometry
Busulfan (Bu) has been used for almost 3 decades in the conditioning of hematopoietic stem cell transplant. Bu has a very diverse… 
Review
2009
Review
2009
Comparison of Outcomes After Allogeneic HSCT for Adult Patients with AML in Remission Using in the Conditioning Regimen Either I.V. Busulfex (BU) Plus Cyclophosphamide (Cy) or TBI Plus Cy: An- ALWP…
Abstract 195 TBI/CY and oral (p.o) Bu/Cy are the traditional allogeneic HSCT (alloHSCT) myeloablative conditioning regimens for… 
2008
2008
305: Thymoglobulin® Rabbit Anti-thymocyte Globulins (r-ATG) Induces Faster Platelet Recovery and does not Suppress Granulocyte Engraftment in a Non-myeloablative Stem Cell Transplantation Setting
2006
2006
A case of therapy-related acute myeloid leukemia associated with inv(16), with subsequent development of t(9;22)
A case of therapy-related acute myeloid leukemia associated with inv(16), with subsequent development of t(9;22) 
2006
2006
A prompt graft-versus-thalassemia effect upon withdrawal of cyclosporine A in a child who received allogeneic peripheral blood stem cell transplantation
A prompt graft-versus-thalassemia effect upon withdrawal of cyclosporine A in a child who received allogeneic peripheral blood… 
2005
2005
Successful engraftment following allogeneic stem cell transplantation with busulfan as a
Busulfan, a sulfonic acid ester, is an alkylating agent with potent toxicity for hematopoietic and sinusoidal endothelial cells… 
2004
2004
Hematopoietic Stem-Cell Transplantation from Unrelated Donors in Elderly Patients (> 55 Years): Older Age Is No Longer a Contraindication When Using Reduced Intensity Conditioning.
Allogeneic stem-cell transplantation (SCT) is a potentially curative approach for patients (pts) with hematologic malignancies… 
2003
2003
208A limited sampling strategy (LSS) to target systemic exposure (SE) of busulfex (Busulfan) injection (IVBU) in pediatric patients (PEDS)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)